设为首页 加入收藏

TOP

INLYTA (axitinib) tablet 阿西替尼片(十七)
2013-06-29 23:13:47 来源: 作者: 【 】 浏览:11489次 评论:0
fects of INLYTA include:
 • diarrhea (frequent or loose bowel movements)
 • high blood pressure
 • tiredness or feeling weak
 • decreased appetite
 • nausea
 • hoarseness
 • rash, redness, itching or peeling of your skin on your hands and feet
 • decreased weight
 • vomiting
 • constipation
 
Tell your doctor if you have any side effect that bothers you or that does not go away.
 
These are not all the possible side effects of INLYTA. For more information, ask your doctor or pharmacist.
 
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
 
How should I store INLYTA?
•Store INLYTA at room temperature between 68°F to 77°F (20°C to 25°C).
 
Keep INLYTA and all medicines out of the reach of children.

General information about INLYTA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use INLYTA for a condition for which it was not prescribed. Do not give INLYTA to other people, even if they have the same symptoms you have. It may harm them.
 
This Patient Information leaflet summarizes the most important information about INLYTA. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about INLYTA that is written for healthcare professionals.

For more information, go to www.inlyta.com or call 877-744-5675.

What are the ingredients in INLYTA?

Active ingredient: axitinib
 
Inactive ingredients: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and Opadry® II red 32K15441. The Opadry II red 32K15441 film coating contains: lactose monohydrate, HPMC 2910/Hypromellose 15cp, titanium dioxide, triacetin (glycerol triacetate), and red iron oxide.
 
This Patient Information has been approved by the U.S. Food and Drug Administration.
LAB-0438-1.0
 
January 2012
PRINCIPAL DISPLAY PANEL - 1 mg Bottle Label

Pfizer

NDC 0069-0145-01
 
Inlyta®
(axitinib) tablets

1 mg

180 Tablets
 
Rx only

PRINCIPAL DISPLAY PANEL - 5 mg Bottle Label

Pfizer

NDC 0069-0151-11
 
Inlyta®
(axitinib) tablets

5 mg

60 Tablets
 
Rx only

INLYTA
axitinib tablet, film coated

Product Information

Product Type

HUMAN PRESCRIPTION DRUG

Item Code (Source)

NDC:0069-0145
Route of Administration

ORAL

DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name

Basis of Strength

Strength

axitinib (axitinib)

axitinib

1 mg

Inactive Ingredients

Ingredient Name

Strength
cellulose, microcrystalline

lactose monohydrate
croscarmellose sodium
magnesium stearate

titanium dioxide

triacetin

ferric oxide red

HYPROMELLOSE 2910 (15000 MPA.S)

Product Characteristics
Color

RED

Score

 no score
Shape

OVAL

Size

9mm

Flavor

Imprint Code

 Pfizer;1;XNB

Contains
Packaging
#
Item Code

Package Description

Multilevel Packaging
1
NDC:00

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 14 15 16 17 18 下一页 尾页 17/18/18
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Vfend (Voriconazole) 下一篇Victrelis(boceprevir) Capsules

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位